Orion Visual Cortical Prosthesis System
Artificial vision for profound blindness (e.g., glaucoma, diabetic retinopathy, optic nerve injury)
Early Feasibility StudyActive
Key Facts
Indication
Artificial vision for profound blindness (e.g., glaucoma, diabetic retinopathy, optic nerve injury)
Phase
Early Feasibility Study
Status
Active
Company
About Cortigent
Cortigent is a neuroscience-focused medical device company, spun out from Vivani Medical, with a mission to restore lost body functions via targeted brain-surface stimulation. Its core achievement is building upon the legacy of the first FDA-approved retinal prosthesis (Argus II) to develop the next-generation Orion visual cortical prosthesis and a stroke motor recovery system. The company's strategy leverages a proprietary high-channel-count platform to address large neurological indications, though its path is complicated by its subsidiary status and a recently withdrawn planned spin-off from its parent company.
View full company profile